Left Main Percutaneous Coronary Intervention Registry in Istanbul Medipol University Hospital

Medipol University3,620 enrolled

Overview

This hospital-based registry study at Istanbul Medipol University Hospital focuses on documenting and analyzing the clinical and demographic characteristics, procedural-related aspects, and both short and long-term outcomes of patients undergoing left main coronary artery percutaneous coronary intervention (PCI). The study aims to identify predictors for adverse clinical outcomes in patients treated for left main coronary artery disease.

Study Type

OBSERVATIONAL

Enrollment

3,620

Conditions

Coronary Artery Disease Left Main Coronary Artery Disease

Interventions

Percutaneous coronary interventionDEVICE

balloon angioplasty, stent implantation, atherectomy, intravascular ultrasound.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients undergoing any PCI procedure(s) in given timeframe will be included in this registry Exclusion Criteria: * Patients with no informed consent

Locations (1)

Istanbul Medipol University

Istanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

Incidence of Major Adverse Cardiac Events (MACE) within One Year Following Left Main Coronary Artery PCI

The primary outcome measure will be the incidence of major adverse cardiac events (MACE) within one year post-procedure in patients undergoing left main coronary artery PCI. MACE is defined as a composite of clinically significant endpoints including all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, and any revascularization procedures required after the initial PCI.

Time frame: up to 1 month, 3 months, 1 year

Secondary Outcomes

Ischemia-Driven Target Vessel Revascularization (ID-TVR) Ischemia-Driven Target Vessel Revascularization (ID-TVR)

Revascularization procedure that is performed on a previously treated vessel in patients who have developed ischemia.

Time frame: 1 year

Procedure-Related Complications Within 30 Days of PCI

This outcome will document the incidence of procedure-related complications, including bleeding, vascular complications, or acute kidney injury, occurring within 30 days post-PCI.

Time frame: 1 month

Health-Related Quality of Life (HRQoL) Scores One Year After PCI

Health-related quality of life using standardized questionnaire (SF-36) one year after the PCI procedure

Time frame: 1 year

Rate of stent thrombosis

Probable or definite stent thrombosis

Time frame: 1 month, 3 months, 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.